Cognitive dysfunction in Multiple Sclerosis

Frontiers in Neurology

Volumn MAY, Issue , 2012, Pages

  Guimarães, Joana ^a,b   Sá, Maria José ^a,c  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Cognition; Multiple sclerosis; Neuropsychological batteries

Indexed keywords

EID: 84865973828     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00074     Document Type: Article

References (81)

1. Amato, M. P., Bartolozzi, M. L., Zipoli, V., Portaccio, E., Mortilla, M., Guidi, L., Siracusa, G., Sorbi, S., Federico, A., and De Stefano, N. (2004). Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 63, 89-93.
2. Archibald, C. J., and Fisk, J. D. (2000). Information processing efficiency in patients with multiple sclerosis. J. Clin. Exp. Neuropsychol. 22, 686-701.
3. Arnett, P. A., and Strober, L. B. (2011). Cognitive and neurobehavioral features in multiple sclerosis. Expert Rev. Neurother. 11, 411-424.
4. Audoin, B., Duong, V., and Malikova, I. (2006). Functional magnetic resonance imaging and cognition at the very early stage of MS.J. Neurol Sci. 245,87-91.
5. Barbosa, F., Sousa, C., Rio, M. E., Reis, J., Abreu, P., Mendonça, T., Guimarães, J., Martins, C., and Sá, M. J. (20 11a). Cognition in multiple sclerosis: evaluation of the longitudinal course. Sinapse 11,68-69.
6. Barbosa, F., Sousa, C., Nogueira-Silva, L., and Sá, M. J. (2011b). Cognitive rehabilitation in multiple sclerosis. Sinapse 11, 61.
7. Basser, P. J., and Pierpaoli, C. (1996). Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B 111, 209-219.
8. Beatty, W. W., Goodkin, D. E., Mon-son, N., and Beatty, P. A. (1989). Cognitive disturbances in patients with relapsing remitting multiple sclerosis. Arch. Neurol. 46, 1113-1119.
9. Benedict, R. H., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N., and Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function in multiple sclerosis. J. Int. Neuropsy chol Soc. 12, 549-558.
10. Benedict, R. H., Fischer, J. S., Archibald, C. J., Arnett, P. A., Beatty, W. W., Bobholz, J., Chelune, G. J., Fisk, J. D., Langdon, D. W., Caruso, L., Foley, F., LaRocca, N. G., Vowels, L., Weinstein, A., DeLuca, J., Rao, S. M., and Munschauer, E (2002). Minimal neuropsychological assess ment of MS patients: a consen sus approach. Clin. Neuropsychol. 16, 381-397.
11. Benedict, R. H. B., and Zivadinov, R. (2007). Reliability and validity of neuropsychological screening and assessment strategies in MS. J. Neurol. 254(Suppl. 2), II/22-II/25.
12. Bergendal, G., Fredrikson, S., and Almkvist, O. (2007). Selective decline in information processing in subgroups of multiple sclerosis: an 8 year old longitudinal study. Eur. Neurol. 57, 193-202.
13. Brissart, H., Daniel, F., Morele, E., Leroy, M., Debouverie, M., and Defer, G. L. (2011). Cognitive rehabilitation in multiple sclerosis: a review of the literature. Rev. Neurol. 167, 280-290.
14. Calabrese, M., Agosta, F., and Rinaldi, F. (2009). Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch. Neurol. 66, 1144-1150.
15. Calabrese, P., and Penner, I. K. (2007). Cognitive dysfunctions in multiple sclerosis - a "multiple disconnection syndrome". J. Neurol. 254(Suppl. 2), II/ 18-II/21.
16. Chiaravalloti, N. D., and DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. Lancet Neurol. 7, 1139-51.
17. Christodoulou, C., MacAllister, W. S., McLinskey, N. A., and Krupp, L. B. (2008). Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option? CNS Drugs 22, 87-97.
18. Christodoulou, C., Melville, P., Scherl, W. F., Macallister, W. S., Elkins, L. E., and Krupp, L. B. (2006). Effects of donepezil on memory and cognition in multiple sclerosis. J. Neurol. Sci. 245, 127-136.
19. Cohen, J. A., Cutter, G. R., Fischer, J. S., Goodman, A. D., Heidenre-ich, E R., Kooijmans, M. F., San-drock, A. W., Rudick, R. A., Simon, J. H., Simonian, N. A., Tsao, E. C., Whitaker, J. N., and IMPACT Investigators. (2002). Benefit of interferon b-1a on MSFC progression in secondary progressive MS. Neurology 59, 679-687.
20. Comi, G. (2010). Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis. Neurol. Sci. 31(Suppl. 2), S261-S264.
21. Dineen, R. A., Vilisaar, J., Hlinka, J., Bradshaw, C. M., Morgan, P. S., Constantinescu, C. S., and Auer, D. P. (2009). Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132, 239-249.
22. Doraiswamy, P. M., and Rao, S. M. (2004). Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology 63, 1552-1553.
23. Engel, C., Greim, B., and Zettl, U. K. (2007). Diagnostics of cognitive dysfunctions in multiple sclerosis. J. Neurol. 254, II/30-II/34.
24. European Study Group. (1998). Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. Lancet 352,1491-1497.
25. Ferreira, M. L. B. (2010). Cognitive deficits in multiple sclerosis. A systematic review. Arq. Neuropsiquiatr. 68, 632-641.
26. Fischer, J. S., Priore, R. L., Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Goodkin, D. E., Granger, C. V., Simon, J. H., Grafman, J. H., Lezak, M. D., O'Reilly Hovey, K. M., Perkins, K. K., Barilla-Clark, D., Schacter, M., Shucard, D. W., Davidson, A. L., Wende, K. E., Bourdette, D. N., and Kooijmans-Coutinho, M. E (2000). Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann. Neurol. 48, 885-892.
27. Foong, J., Rozewicz, L., Quaghebeur, G., Davie, C. A., Kartsounis, L. D., Thompson, A. J., Miller, D. H. M., and Ron, A. (1997). Executive function in in multiple sclerosis. The role of frontal lobe pathology. Brain 120, 15-26.
28. Geurts, J. J., Bo, L., Pouwels, P. J., Castelijns, J. A., Polman, C. H., and Barkhof, E (2005). Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am. J. Neuroradiol. 26, 572-577.
29. He, D., Zhou, H., Guo, D., Hao, Z., and Wu,B. (2011). Pharmacologic treatment for memory disorder in multiple sclerosis. Cochrane Database Syst. Rev. 5, CD008876.
30. Huijbregts, S. C., Kalkers, N. F., de Sonneville, L. M., de Groot, V., and Polman, C. H. (2004). Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 63, 335-339.
31. Huolman, S., Hämäläinen, P., Vorobyev, V., Ruutiainen, J., Parkkola, R., Laine, T., and Hämäläinen, H. (2011). The effects of rivastig-mine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue. Mult. Scler. 17, 1351-1361.
32. Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H. P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E. W., Metzig, C., Bauer, L., Lanius, V., Sandbrink, R., Pohl, C., and BENEFIT Study Group. (2009). Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol. 8, 987-997.
33. Kealey, S. M., Kim, Y., Whiting, W. L., Madden, D. J., and Provenzale, J. M. (2005). Determination of multiple sclerosis plaque size with diffusion-tensor MR Imaging: comparison study with healthy volunteers. Radiology 236, 615-620.
34. Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., and Revesz, T. (1999). Cortical lesions in multiple sclerosis. Brain 122, 17-26.
35. Kinsinger, S. W., Lattie, E., and Mohr, D. C. (2010). Relationship between depression, fatigue, subjective cog nitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 24, 573-580.
36. Krupp, L. B., Christodoulou, C., Melville, P., Scherl, W. F., MacAllister, W. S., and Elkins, L. E. (2004). Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63, 1579-1585.
37. Krupp, L. B., Christodoulou, C., Melville, P., Scherl, W. F., Pai, L. Y., Muenz, L. R., He, D., Benedict, R. H., Goodman, A., Rizvi, S., Schwid, S. R., Weinstock-Guttman, B., Westervelt, H. J., and Wishart, H. (2011). Mul-ticenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 76, 1500-1507.
38. Krupp, L. B., and Elkins, L. E. (2000). Fatigue and declines in cognitive functioning in multiple sclerosis. The role of frontal lobe pathology. Brain 120, 15-26.
39. Landro, N. I., Celius, E. G., and Sletvoid, H. (2004). Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis. J. Neurol. Sci. 217, 211-216.
40. Langdon, D.W (2010)."Cognitive rehabilitation in multiple sclerosis," in Multiple Sclerosis: Recovery of Function and Neurorehabilitation, eds J. Kesselring, G. Comi, and A. Thompson (New York: Cambridge University Press), 176-182.
41. Langdon, D. W. (2011). Cognition in multiple sclerosis. Curr. Opin. Neurol. 24, 244-249.
42. Langdon, D. W., Wicklein, E. M., Scherer, P., and Fredrikson, S. (2010). Cognition, fatigue, depression and HR-QoL in early multiple sclerosis: results from Cogn-iMS, a multinational longitudinal study. Presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Gothenburg, Sweden.
43. Lovera, J. F., Frohman, E., Brown, T. R., Bandari, D., Nguyen, L., Yadav, V., Stuve, O., Karman, J., Bogardus, K., Heimburger, G., Cua, L., Remingon, G., Fowler, J., Monahan, T., Kil-cup, S., Courtney, Y., McAleenan, J., Butler, K., Wild, K., Whitham, R., and Bourdette, D. (2010). Meman-tine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial. Mult. Scler. 16, 715-723.
44. Lyros, E., Messinis, L., Papageorgiou, S. G., and Papathanasopoulos, P. (2010). Cognitive dysfunction in multiple sclerosis: the effect of pharmacological Interventions. Int. Rev. Psychiatry 22, 35-42.
45. Mendes, A., and Sá, M. J. (2011). Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works. Arq. Neuropsiquiatr. 69, 536-543.
46. Messinis, L., Kosmidis, M. H., Lyros, E., and Papathanasopoulos, P. (2010). Assessment and rehabilitation of cognitive impairment in multiple sclerosis. Int. Rev. Psychiatry 22, 22-34.
47. Montalban,X., and Rio, J. (2006). Inter-ferons and cognition. J. Neurol. Sci. 245, 137-140.
48. Morgen, K., Sammer, G., Courtney, S. M., Wolters, T., Melchior, H., Blecker, C. R., Oschmann, P., Kaps, M., and Vaitl, D. (2006). Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 30,891.
49. Nebel, K., Wiese, H., Seyfarth, J., Gizewski, E. R., Stude, P., Diener, H. C., and Limmroth, V. (2007). Activity of attention related structures in multiple sclerosis. Brain Res. 1151, 150-160.
50. Nelson, F., Datta, S., Garcia, N., Rozario, N. L., Perez, F., Cutter, G., Narayana, P. A., and Wolinsky, J. S. (2011). Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult. Scler. 11, 1122-1129.
51. O'Carroll, C. B., Woodruff, B. K., Locke, D. E., Hoffman-Snyder, C. R., Wellik, K. E., Thaera, G. M., Demaer-schalk, B. M., and Wingerchuk, D. M. (2012). Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic. Neurologist 18, 51-54.
52. Parry, A. M., Scott, R. B., Palace, J., Smith, S., and Mathews, P. M. (2003). Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 126, 2750-2760.
53. Peyser, J. M., Rao, S. M., LaRocca, N. G., and Kaplan, E. (1990). Guidelines for neuropsychological research in multiple sclerosis. Arch. Neurol. 47, 94-97.
54. Piras, M. R., Magnano, I., Canu, E. D., Paulus, K. S., Satta, W. M., Soddu, A., Conti, M., Achene, A., Solinas, G., and Aiello, I. (2003). Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neu-rophysiological findings. J. Neurol. Neurosurg. Psychiatr. 74, 878-885.
55. Pliskin, N. H., Hamer, D. P., Goldstein, D. S., Towle, V. L., Reder, A. T., Noronha, A., and Arnason, B. G. (1996). Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferonbeta-1b. Neurology 47, 1463-1468.
56. Polman, C. H., O'Connor, P. W., Havr-dova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., Toal, M., Lynn, F., Panzara, M. A., San-drock, A. W., and AFFIRM Investigators. (2006). Arandomized, placebo-con trolled trial of natalizumab for relapsing multiple sclerosis. N Engl. J.Med. 354, 899-910.
57. Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., Sandberg-Wollheim, M., Thompson, A. J., Weinshenker, B. G., and Wolinsky, J. S. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann. Neurol. 58, 840-846.
58. Ranjeva, J. P. (2006). Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis. J. Neurol. Sci. 245, 161-167.
59. Ranjeva, J. P., Audoin, B., Au Duong, M. V., Ibarrola, D., Confort-Gouny, S., Malikova, I., Soulier, E., Viout, P., Ali-Chérif, A., Pelletier, J., and Cozzone, P. (2005). Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. Am. I Neuroradiol. 26,119-112.
60. Rao, S. M., and Cognitive Function Study Group of the National Multiple Sclerosis Society. (1990). A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee: Medical College of Wisconsin.
61. Rao, S. M. (1986). Neuropsychology of multiple sclerosis: a critical review. J. Clin. Exp. Neuropsychol. 8, 503-542.
62. Rao, S. M., Grafman, J., DiGuilio, D., Mittenberg, W., Bernardin, L., Leo, G. J., Luchetta, T., and Unverzagt, E (1993). Memory dysfunction in multiple sclerosis: its relation to working memory, semantic encoding and implicit learning. Neuropsychology 7, 364-374.
63. Rao, S. M., Leo, G. J., Bernardin, L., and Unverzagt, F. (1991a). Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. Neurology 41, 685-691.
64. Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., and Unveragt, F. (1991b). Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41, 692-696.
65. Rao, S. M., Leo, G. J., and St Aubin-Faubert, P. (1989). On the nature of memory disturbance in multiple sclerosis. J. Clin. Exp. Neuropsychol. 11,699-712.
66. Rinaldi, F., Calabrese, M., Grossi, P., Puthenparampil, M., Perini, P., and Gallo, P. (2010). Cortical lesions and cognitive impairment in multiple sclerosis. Neurol. Sci. 31(Suppl. 2), S235-S237.
67. Rio, M. E., Sousa, C, Sa, M. J., and Reis, J. (2004). Cognitive dysfunction in multiple sclerosis. Arq. Neuropsiquiatr. 62, 26-27.
68. Rosti-Otajärvi, E. M., and Hämäläi-nen, P. I. (2011). Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst. Rev. 11, CD009131.
69. Rovaris, M., Filippi, M., Falautano, M., Minicucci, L., Rocca, M. A., Mar-tinelli,V., and Comi, G. (1998). Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 50, 1601-1608.
70. Rudick, R. A., Stuart, W H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E. W., Lublin, F. D., Weinstock-Guttman, B., Wynn, D.R., Lynn, F., Panzara, M. A., San-drock, A. W., and SENTINEL Investigators. (2006). Natalizumab plus interferon b-1a for relapsing multiple sclerosis. N Engl. J. Med. 354, 911-923.
71. Sá, M. J., Guimarães, J., Abreu, P., Mendes, A., and Souto, E. B. (2011). Etiopathogenesis, classical immunotherapy and innovative nanotherapeutics for inflammatory neurological disorders. Curr. Nanosci. 7,2-20.
72. Sanfilipo, M. P., Benedict, R. H. B.,Weinstock-Guttman, B., and Bak-shi,R. (2006). Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 66, 685-692.
73. Sastre-Garriga, J., Alonso, J., Renom, M., Arévalo, M. J., González, I., Galán, I., Montalban, X., and Rovira, A. (2011). A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis. Mult. Scler. 17, 457-467.
74. Schulz, D., Kopp, B., Kunkel, A., Faiss, J. H. (2006). Cognition in the early stage of multiple sclerosis. J. Neurol. 253, 1002-1010.
75. Shaygannejad, V., Janghorbani, M., Ashtari, F., Zanjani, H. A., and Zak-izade, N. (2008). Effects of rivastigmine on memory and cognition in multiple sclerosis. Can. J. Neurol. Sci. 35,476-481.
76. Sperling R A., Guttmann, C. R., Hohol, M. J., Warfield, S. K., Jakab, M., Par-ente, M., Diamond, E. L., Daffner, K. R., Olek, M. J., Orav, E. J., Kiki-nis, R., Jolesz, F. A., and Weiner, H. L. (2001). Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch. Neurol. 58, 115-121.
77. Staffen, W., Mair, A., Zauner, H., Unter-rainer, J., Niederhofer, H., Kutzel-nigg, A., Ritter, S., Golaszewski, S., Iglseder,B.,andLadurner,G. (2002). Cognitive function, and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 125, 1275-1282.
78. Strober, L., Englert, J., Munschauer, E, Weinstock-Guttman, B., Rao, S., and Benedict, R. H. B. (2009). Sensitivity of conventional memory tests in multiple sclerosis: comparing the rao brief repeatable neuropsychological battery and the minimal assessment of cognitive function in MS. Mult. Scler. 15, 1077-1084.
79. Summers, M. M., Fisniku, L. K., Anderson, V. M., Miller, D. H., Cipolotti, L., and Ron, M. (2008). Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult. Scler. 14, 197-204.
80. Thornton, A. E., Raz, N., Tucke, K. A. (2002). Memory in multiple sclerosis: contextual encoding deficits. J. Int. Neuropsychol. 8, 395-409.
81. Weinstein, A., Schwid, S. R., Schiffer, R. B., McDermott, M. P., Giang, D. W., and Goodman, A. D. (1999). Neuropsychologic status in multiple sclerosis after treatment with glati-ramer. Arch. Neurol. 56, 319-324. [Erratum in: Arch. Neurol. (2004) 61, 1284].